期刊文献+

肝癌循环肿瘤细胞临床应用研究进展 被引量:4

下载PDF
导出
摘要 原发性肝癌是一种恶性程度高的肿瘤,易复发及转移,其中最常见的转移途径为血行转移。循环肿瘤细胞是肝癌血行转移的中心环节,实时监测循环肿瘤细胞对患者个体化治疗、疗效评估及监测肿瘤复发转移具有很好的价值,使其成为肝癌研究的热点,但由于肝癌循环肿瘤细胞缺乏特异性的细胞表面标记物,为进一步研究及临床应用造成一定的困难。本文就肝癌循环肿瘤细胞常用的检测技术及现阶段所进行的研究结果做一综述。
出处 《肝胆胰外科杂志》 CAS 2016年第1期79-83,共5页 Journal of Hepatopancreatobiliary Surgery
基金 国家自然科学基金项目(81441063) 第二军医大学干细胞与医学研究中心研究生创新实验课题(SCMRC1406)
  • 相关文献

参考文献3

二级参考文献39

  • 1ZhangY, Li J, Cao L, et al. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Semin Oncol, 2012,39(4) :449-460.
  • 2Ye RQ, Lu ZY. International Medicine. 6th ed. Beijing: People's Medical Publishing House, 2004.
  • 3Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol, 2009,10( 1 ) :35-43.
  • 4Carr BI. Some new approaches to the management of hepatocellular carcinoma. Semin Oncol, 2012,39(4) :369-373.
  • 5Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J, 1869,14: 146-147.
  • 6Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor ceils detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol, 2010: 617421.
  • 7Miyamoto DT, Lee R J, Stott SL, et al. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov, 2012,2 ( 11 ) :995-1003.
  • 8Williams SC. Circulating tumor cells. Proc Natl Acad Sci U S A, 2013, 110(13) :4861.
  • 9Yamashita T, Forgues M, Wang W, et aL EpCAM and alpha- fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res, 2008,68 ( 5 ) : 1451-1461.
  • 10Wu LJ, Pan YD, Pei XY, et al. Capturing circulating tumor cells of hepatocellular carcinoma. Cancer Lett, 2012,326 (1) :17-22.

共引文献20

同被引文献57

  • 1Forner A,Llovet IM,Bruix J.Hepatocellular carcinoma[J].Lancet,2012;379:1245-55.
  • 2Sherman M.Hepatocellular carcinoma:epidemiology,risk factors,and screening[J].Semin Liver Dis,2005;25(2):143-54.
  • 3Rodriguez-Peralvarez M,Luong TV,Andreana L,et al.A systematic review of microvascular invasion in hepatocellular carcinoma:diagnostic and prognostic variability[J].Ann Surg Oncol,2013;20(1):325-39.
  • 4Kornelius Schulze,Christin Gasch,Katharina Staufer,et al.Presence of Ep CAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma[J].Int J Cancer,2013;133(9):2165-71.
  • 5Sun YF,Xu Y,Yang XR,et al.Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection[J].Hepatology,2013;57(4):1458-68.
  • 6Wong KF,Xu Z,Chen J,et al.Circulating markers for prognosis of hepatocellular carcinoma[J].Exp Opin Med Diagn,2013;7(4):319-29.
  • 7Liu MC,Shields PG,Warren RD,et al.Circulating tumor cells:a useful predictor of treatment efficacy in metastatic breast cancer[J].J Clin Oncol,2009;27:5153-9.
  • 8Kelley RK,Magbanua MJM,Butler TM,et al.Circulating tumor cells in hepatocellular carcinoma:a pilot study of detection,enumeration,and next-generation sequencing in cases and controls[J].BMC Cancer,2015;15:206.
  • 9吕文平,李智华,王曙光,别平,董家鸿.肝细胞癌肝动脉栓塞化疗降期治疗后根治性切除[J].中华消化外科杂志,2008,7(3):186-188. 被引量:7
  • 10郑建,李丽.循环血肿瘤细胞在预测转移性乳腺癌化疗疗效中的应用[J].中华肿瘤防治杂志,2009,16(3):193-196. 被引量:6

引证文献4

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部